J. Kopp
Nephrology · 2000–2017
A researcher in the Science corpus: 7 papers; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Nephrology — 16 citations into it; #74 of 92 by trust here, #50 by citations
- Molecular Biology — 15 citations into it; #16,630 of 17,773 by trust here, #9,727 by citations
Whom J. Kopp trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts J. Kopp overall
Papers from J. Kopp's perspective
Ordered by how strongly the researchers J. Kopp trusts endorse each paper. Same corpus, a different order for every researcher.
- Genome-wide association study of prostate cancer identifies a second risk locus at 8q24 (Nature Genetics)
- Pathologic classification of focal segmental glomerulosclerosis: a working proposal. (American Journal of Kidney Diseases)
- Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis (Nature Medicine)
- α-Galactosidase A deficiency. Fabry disease
- Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. (American Journal of Human Genetics)
- A Fine-Scale Map of Recombination Rates and Hotspots Across the Human Genome (Science)
- A new statistical method for haplotype reconstruction from population data. (American Journal of Human Genetics)
- A genome-wide association study identifies novel risk loci for type 2 diabetes (Nature)
- Principal components analysis corrects for stratification in genome-wide association studies
- Polygenic susceptibility to breast cancer and implications for prevention (Nature Genetics)
Their papers
- Identification of renox, an NAD(P)H oxidase in kidney. (2000) — 870 citations
- Focal Segmental Glomerulosclerosis. (2017) — 787 citations
- APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease (2013) — 721 citations
- APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. (2011) — 783 citations
- Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans (2010) — 1,942 citations
- MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis (2008) — 684 citations
- Enzyme replacement therapy in Fabry disease: a randomized controlled trial. (2001) — 1,282 citations